Target intelligence / Profile preview

67-kDa laminin receptor (RPSA) (67LR)

Target
67LR
Molecular classification
Receptor, Ribosomal protein, RNA-binding protein
01

Overview

The 67-kDa laminin receptor (67LR) is a non-integrin cell surface receptor that plays a dual role as a structural component of the 40S ribosome (as its 37-kDa precursor, RPSA) and a high-affinity receptor for laminin (UniProt P08865). In the context of gene therapy, 67LR serves as a critical co-receptor for the adeno-associated virus serotype 9 (AAV9), facilitating viral attachment and internalization into target cells, particularly in the central nervous system and muscle tissues (Akache et al., 2006). AAV9 transduction also depends on other co-receptors, including terminal galactose residues for initial attachment and the adeno-associated virus receptor (AAVR/KIAA0319L) for endosomal escape and trafficking (Pillay et al., 2016). Beyond its role in viral entry, 67LR is frequently overexpressed in various cancers, where it correlates with increased metastatic potential and poor prognosis by mediating tumor cell adhesion to the basement membrane (Montuori et al., 2012). It also serves as a receptor for other pathogens, including the Dengue virus and prions, and is the primary target for the green tea polyphenol epigallocatechin gallate (EGCG), which induces cancer-specific apoptosis through 67LR-mediated signaling (Tachibana et al., 2004). Therapeutic strategies involving 67LR include its utilization for targeted AAV-mediated gene delivery and the development of antibodies or small molecules to inhibit its role in cancer progression.

Other names
LamR37-kDa laminin receptor precursor37LRPRibosomal protein SARPSALRP/LRLAMR1p40
02

Mechanism of action

67LR facilitates AAV9 attachment and internalization into host cells. In cancer, it promotes metastasis by mediating cell adhesion to laminin-1 in the basement membrane. It also acts as a receptor for EGCG, triggering a cGMP-dependent apoptotic pathway.

03

Biological functions

Cell adhesionCell migrationProtein translationViral entryApoptosis regulation
04

Disease associations

CancerInfectionNeurodegenerative disease
05

Safety considerations

Widespread expression of 67LR may lead to off-target transduction of AAV9 vectors in non-target tissues like the liverPotential disruption of the receptor's normal ribosomal functionsImmunogenicity of viral capsids
06

Interacting drugs

Onasemnogene abeparvovec

3 more in the full profile.

07

Biomarkers

67LR expression levelsRPSA mRNA levels

Beyond the preview

Go deeper on 67-kDa laminin receptor (RPSA) (67LR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 67-kDa laminin receptor (RPSA) (67LR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call